Editas Medicine, Inc. — Director's Dealing 2016

Jul 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-07-28

Reporting Person: Vaishnaw Akshay (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-28	Stock Option (right to buy)	$27.28	A	23076	Acquired	2026-07-27	Common Stock (23076)	Direct

Footnotes

F1: This option was granted on July 28, 2016 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on July 28, 2017 through July 28, 2019.